SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (286)8/19/2002 3:18:37 PM
From: scaram(o)uche  Read Replies (1) of 598
 
United States Patent Application 20020106705
Kind Code A1
Beckmann, Holger ; et al. August 8, 2002

--------------------------------------------------------------------------------
Detection method for monitoring beta tubulin isotype specific modification

Abstract
This invention relates to monoclonal antibodies that recognize modified .beta.-tubulin isotypes, methods of using such antibodies to detect modified .beta.-tubulin isotypes, methods of using such antibodies to monitor .beta.-tubulin modifying agents administered to a patient, methods of using such antibodies to isolate modified .beta.-tubulin, and methods of detecting the anti-modified .beta.-tubulin antibodies.

--------------------------------------------------------------------------------
Inventors: Beckmann, Holger; (El Cerrito, CA) ; Santha, Edit; (Cupertino, CA)
Correspondence Name and Address: TOWNSEND AND TOWNSEND AND CREW, LLP
TWO EMBARCADERO CENTER
EIGHTH FLOOR
SAN FRANCISCO
CA
94111-3834
US


Assignee Name and Adress: Tularik Inc.
Two Corporate Drive
So. San Francisco
CA
94080


Serial No.: 934025
Series Code: 09
Filed: August 21, 2001
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext